US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Tekmira Pharmaceuticals Corp. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Tekmira Pharmaceuticals Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Novavax, Inc. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Novavax, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Colby Pharmaceutical Company - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Pulmatrix, Inc. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Pulmatrix, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Chipscreen Biosciences Ltd - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Chipscreen Biosciences Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Capsugel, Inc. - Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ...  |  read more...
USD 125
Clovis Oncology, Inc. (CLVS) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Helix BioMedix, Inc. - Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ...  |  read more...
USD 125
Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Octapharma AG - Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ...  |  read more...
USD 125
Oramed Pharmaceuticals, Inc. (ORMP) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Eisai Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making ...  |  read more...
USD 1,495
Eli Lilly Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and ...  |  read more...
USD 1,495
Emergent BioSolutions Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Emergent BioSolutions and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company ...  |  read more...
USD 1,495
Enzo Biochem Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Enzo Biochem and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company ...  |  read more...
USD 1,495
Galapagos Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... understand Galapagos and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The ...  |  read more...
USD 1,495
Hospira Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making ...  |  read more...
USD 1,495
Intuitive Surgical Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Intuitive Surgical and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company ...  |  read more...
USD 1,495
Isis Pharmaceuticals Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Isis Pharmaceuticals and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company ...  |  read more...
USD 1,495
Johnson & Johnson / Janssen Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Johnson & Johnson and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and ...  |  read more...
USD 1,495
Lundbeck Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... Lundbeck and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report ...  |  read more...
USD 1,495
Medivation Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... understand Medivation and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The ...  |  read more...
USD 1,495
Menarini Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... Menarini and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report ...  |  read more...
USD 1,495
Merck & Co Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Merck & Co and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and ...  |  read more...
USD 1,495
1  2  3    5    7  8  9  10